SMMT (SMMT) Price Target

Track Wall Street analyst price targets and coverage changes.

Consensus Price Target

$38.25

▲ 56.8% Upside
based on current price $24.39
High Target
$44.00
Median Target
$39.50
Low Target
$30.00
Analyst Coverage
Last Month
3
$39.33
Last Quarter
5
$39.00
Last Year
10
$34.90
Individual Price Targets
Latest Analyst Coverage
Date Analyst Firm Target Price When Posted Upside News
Apr 28, 2025 H.C. Wainwright $44.00 $24.11 82.5% Summit Therapeutics selloff Friday on data overdone, says H.C. Wainwright
Apr 25, 2025 Wells Fargo $30.00 $23.47 27.8% Wells says Summit, Akeso data 'not the bull case,' but not 'bear case either'
Apr 25, 2025 Kelly Shi Jefferies $44.00 $25.61 71.8% Jefferies uncovers China approval for Summit Therapeutics, ups target
Mar 26, 2025 Yigal Nochomovitz Summit Redstone Partners $35.00 $19.89 76.0% Summit Therapeutics upgraded to Buy from Neutral at Citi
Feb 28, 2025 Summit Redstone Partners $42.00 $20.69 103.0% Goldman starts Summit Therapeutics with a Buy on ivonescimab potential
Nov 04, 2024 Reni Benjamin JMP Securities $32.00 $19.96 60.3% JMP Securities Starts Summit Therapeutics plc (SMMT) at Market Outperform
Sep 27, 2024 Yigal Nochomovitz Summit Redstone Partners $23.00 $20.89 10.1% Citi Downgrades Summit Therapeutics plc (SMMT) to Neutral, 'Valuation Looking Fair for Now'
Sep 25, 2024 Brad Canino Stifel Nicolaus $40.00 $24.00 66.7% Summit Therapeutics plc (SMMT) PT Raised to $40 at Stifel
Sep 16, 2024 Mitchell Kapoor H.C. Wainwright $45.00 $31.93 40.9% Summit Therapeutics price target raised to $45 from $30 at H.C. Wainwright
Jun 03, 2024 Brad Canino Stifel Nicolaus $14.00 $8.69 61.2% Summit Therapeutics plc (SMMT) PT Raised to $14 at Stifel

Related Metrics

Explore detailed financial metrics and analysis for SMMT.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio